Jogarao Gobburu, MBA, PhD
- 2Articles
- 9.6KReads1
- 2011–2012Active
- 22Collaborators
- 106Citations2
About
Jogarao Gobburu, MBA, PhD, has published research focused on the pharmacogenetics of depression treatment and the clinical evaluation of antidepressant medications. His work includes studies on the use of CYP2D6 genotype information to guide pimozide dosing and the clinical basis for the FDA approval of vilazodone as a new antidepressant. Gobburu's articles appeared in Psychiatrist.com between 2011 and 2012.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
